# ValenTx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/valentx

- Industry: Medical Devices & Equipment
- Headquarters: Maple Grove, US
- Website: www.valentx.com
- Total disclosed funding: $28M
- Latest round: Series B (Sep 7, 2009)
- Investors on record: 7

## About

Founded in 2002 and based in Minnesota, US, ValenTx, Inc. operates as a provider of medical devices and non-surgical treatments to cure obesity and metabolic disorders such as type-2 diabetes and hypertension. The company offers endoluminal bypass therapy that mimics the permanent anatomical changes made by the Roux-en-Y gastric bypass procedure but does not require surgery and gastric stapling.

## Funding rounds

- Series B, Sep 7, 2009, $22M — TGap Ventures, Affinity Capital Management, EDF Ventures, SV Health Investors, Sapient Capital, Medtronic Ventures, Kaiser Permanente Ventures
- Series A, Jul 13, 2006, $0.9M — TGap Ventures, EDF Ventures
- Series A, May 3, 2006, $5.2M — TGap Ventures, Affinity Capital Management, EDF Ventures, Sapient Capital, Kaiser Permanente Ventures

## Investors

- TGap Ventures (https://capitalatlas.ai/funds/tgap-ventures) — Series A, Series B
- Affinity Capital Management (https://capitalatlas.ai/funds/affinity-capital-management) — Series A, Series B
- EDF Ventures (https://capitalatlas.ai/funds/edf-ventures) — Series A, Series B
- Sapient Capital (https://capitalatlas.ai/funds/sapient-capital) — Series A, Series B
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B
- Medtronic Ventures (https://capitalatlas.ai/funds/medtronic-ventures) — Series B